Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6141762 | 0.97 | CA1 (0.55) | CA1CA2CA7CA9CA12 | |
| SCHEMBL11536088 | 0.78 | CA1 (0.65) | CA1CA2CA7CA9CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL8489 | 0.76 | CA1 (1.00) | CA1CA2CA7CA9CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL21802643 | 0.76 | CA1 (1.00) | CA1CA2CA7CA9CA12 | |
| Lithium SCHEMBL2300586 | 0.76 | CA1 (0.61) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2885053 | 0.74 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL559995 | 0.74 | ALDH1A1 (0.58) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL21825862 | 0.74 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL109480 | 0.74 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL15105231 | 0.74 | CA1 (0.58) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118754917-B | Alpha-diimine ligand compound, nickel complex, composite complex, preparation method and application thereof | 安徽中科科乐化工科技有限责任公司 | 2025-01-17 | — | — | CN | claimed |
| CN-118754917-A | Alpha-diimine ligand compound, nickel complex, composite complex, preparation method and application thereof | 安徽中科科乐化工科技有限责任公司 | 2024-10-11 | — | — | CN | claimed |
| CN-108178724-A | The preparation method of compound | 四川大学 | 2018-06-19 | — | — | CN | claimed |
| CN-106397320-A | A synthetic method of a hexahydro cis dimethyl bridged-ring compound | 和鼎（南京）医药技术有限公司 | 2017-02-15 | — | — | CN | claimed |
| CN-1289190-C | Process for preparing aryl compounds | BAYER AG (DE) | 2006-12-13 | — | — | CN | claimed |
| CN-1466487-A | Process for preparing aryl compounds | — | 2004-01-07 | — | — | CN | claimed |
| EP-1324964-A2 | METHOD FOR PRODUCING ARYL COMPOUNDS | Bayer Aktiengesellschaft (DE) | 2003-07-09 | — | — | EP | claimed |
| US-20020077250-A1 | Process for preparing aryl compounds | BAYER AKTIENGESELLSCHAFT (DE) | 2002-06-20 | — | — | US | claimed |
| WO-2002026665-A2 | METHOD FOR PRODUCING ARYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-04-04 | — | — | WO | claimed |
| CN-116535446-B | C (C)2Symmetrical chiral diphosphine ligand and application thereof in asymmetric hydrogenation reaction | 凯特立斯（深圳）科技有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-116554087-B | Method for synthesizing carbazole compounds by photoinduction | 陕西师范大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-118754917-B | Alpha-diimine ligand compound, nickel complex, composite complex, preparation method and application thereof | 安徽中科科乐化工科技有限责任公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-113999232-B | MAT2A inhibitors | 南京正大天晴制药有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-118754917-A | Alpha-diimine ligand compound, nickel complex, composite complex, preparation method and application thereof | 安徽中科科乐化工科技有限责任公司 | 2024-10-11 | — | — | CN | disclosed |
| US-5098908-A | 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors | MERCK & CO., INC. (US) | 1992-03-24 | — | — | US | disclosed |
| EP-0465142-A1 | 17Beta-acyl-3-carboxy-androsta-3, 5-dienes as testosterone 5alpha-reductase inhibitors | MERCK & CO. INC. (US) | 1992-01-08 | — | — | EP | disclosed |
| EP-0465123-A2 | New intermediates in the synthesis of 17beta-acyl-3-carboxy-androsta-3,5-dienes | MERCK & CO. INC. (US) | 1992-01-08 | — | — | EP | disclosed |
| EP-0462661-A2 | Novel 17beta-hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones as testosterone reductase inhibitors | MERCK & CO. INC. (US) | 1991-12-27 | — | — | EP | disclosed |
| US-5075450-A | Intermediates in the synthesis of 17β-acyl-3-carboxy-androsta-3,5-dienes | MERCK & CO., INC. (US) | 1991-12-24 | — | — | US | disclosed |
| US-3961066-A | ANALGESICS, ANTITUSSIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077250-A1 | Process for preparing aryl compounds | TYR, ABL1, AHR | CA1 4056/4885CA2 2736/4885CA7 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.